Breaking News
Get 40% Off 0
Join +750K new investors every month who copy stock picks from billionaire's portfolios Sign Up Free
Close

EBM Technologies (8409)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
23.30 +0.20    +0.87%
14/06 - Closed. Currency in TWD ( Disclaimer )
  • Volume: 42
  • Bid/Ask: 19.15 / 19.35
  • Day's Range: 23.20 - 23.45
Type:  Equity
Market:  Taiwan
ISIN:  TW0008409004 
EBM Tech 23.30 +0.20 +0.87%

EBM Technologies Company Profile

 
Get an in-depth profile of EBM Technologies, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryHealthcare Equipment & Supplies
SectorHealthcare
Employees

-

Equity Type

ORD

EBM Technologies Incorporated engages in the development and marketing of software and integrity solutions to the health sector in Taiwan and internationally. The company offers Enterprise PACS (picture archiving and communication systems) solutions, including SoliPACS that unites various products of the radiology, mammography, and dental fields; SoliPACS Gateway, a DICOM gateway; SoliPACS Server, an interface between HIS and RIS patient data and PACS; SoliPACS Web Viewer, which enables radiologists and physicians to view, compare, utilize, and select DICOM-compliant images; SoliPACS Report, offers a tool for generating customized reports; and Advanced Server Archive, a PACS storage system. It also provides UDE (Ubiquitous Diagnostic Environment) App, which converts standard iPad Pro into a standalone DICOM server, viewer, display, and Al all in one; MobiPACS Server to store, process, and retrieve image files for mobile devices; MobiPACS App, an in mobile medical image viewing app; MobiPACS Web Viewer for viewing images from Internet-enabled end devices; MobiPACS Share, a cloud-based platform; and MobiPACS Multi, supports doctors to connect various iPads/iPad Pros for image display. In addition, the company offers Vital-Sign On-the-Go, a patient monitoring solution; Rad@, for viewing medical-grade images and diagnose; Digital Pathology Scanner, transforms physical slides to whole side images; AgileRIS App, an offline reporting solution; EPS Pi, a viewer ready DICOM device; and UniGate_i (UGI) App. Further, it provides Telemed, which interlinks medical facilities; Electronic Medical Record, a digital version of the paper-based individual medical record for patients’ medical history; Personal Health Record, offers electronic access to the individual’s medical history; and eHealth solutions for retrieving and reviewing patient images, vital sign data, and ECG waveforms. The company was founded in 1988 and is headquartered in Taipei, Taiwan.

Contact Information

Address No. 516, Neihu Road 5th Floor
Section 1 Taipei,
Taiwan
Phone 886 2 8751 4567
Fax 886 2 8751 3300

Top Executives

Name Age Since Title
An Ding Li - - Director
Long Pan - - Founder, CEO & Chairman
Zheng Zhong Ceng - - Supervisor
Jia Juan Pan - - Director
Chong Qi Cai - - Director
Shi Bei Huang - - Supervisor
Qi Cai Chen - - Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

8409 Comments

Write your thoughts about EBM Technologies
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email